924 material Form 8-K filings that 737 companies we cover made with the SEC in January 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
NRG Energy completed its acquisition of 18 natural-gas-fired generation facilities and the CPower virtual power plant platform from LS Power, which the company says doubles its generation fleet to about 25 GW. The purchase price included $6.4 billion in cash, 24,250,000 newly issued NRG common shares, and about $3.2 billion of assumed debt, so the deal adds both cash and debt obligations and dilutes existing holders.
Purchase price: $6.4 billion in cash, 24,250,000 shares of common stock issued to sellers, and about $3.2 billion of assumed debt.
Acquired 18 natural-gas-fired facilities totaling about 13 GW, plus CPower's commercial and industrial VPP platform.
Cash portion funded partly by October 8, 2025 notes ($1.25 billion senior secured and $3.65 billion senior unsecured) and revolver borrowings.
Sellers' shares are locked up until July 30, 2026; NRG must file a Form S-3 resale registration for those shares; $1,500 million Lightning notes due 2032 and a $1.75 billion term loan were also disclosed.
First Hawaiian reported fourth-quarter 2025 net income of $69.9 million, or $0.56 per diluted share, down from $73.8 million, or $0.59 per share, in the prior quarter but up from $52.5 million, or $0.41 per share, a year earlier. The Board also adopted a stock repurchase program of up to $250.0 million and declared a quarterly dividend of $0.26 per share.
Net income $69.9 million vs $73.8 million in Q3 2025 and $52.5 million in Q4 2024
Diluted EPS $0.56 vs $0.59 in Q3 2025 and $0.41 in Q4 2024
Provision for credit losses $7.7 million vs $4.5 million in Q3 2025
Board adopted a repurchase program for up to $250.0 million; quarterly dividend of $0.26 payable February 27, 2026
Gentex reported fourth-quarter 2025 consolidated net sales of $644.4 million, up 19% year over year with the VOXX acquisition included, and diluted EPS of $0.43 versus $0.39. Core Gentex sales were about flat at $541.0 million, while full-year 2025 diluted EPS fell to $1.74 from $1.76 and net income attributable to Gentex declined to $384.8 million from $404.5 million. The company also gave 2026 revenue guidance of $2.60 to $2.70 billion and 2027 revenue guidance of $2.75 to $2.85 billion.
Q4 2025 consolidated net sales $644.4 million, up from $541.6 million; core Gentex sales $541.0 million
Colgate-Palmolive reported fourth quarter 2025 net sales up 5.8% to $5,230 million, but GAAP diluted EPS was $(0.05) versus $0.90 a year earlier, driven by a $794 million after-tax goodwill and intangible asset impairment tied to the skin health business. Excluding these items, Base Business EPS rose 4% to $0.95. The company also guided 2026 net sales growth of 2% to 6% and GAAP double-digit EPS growth.
Q4 2025 net sales rose 5.8% to $5,230 million; organic sales rose 2.2%.
GAAP diluted EPS was $(0.05), down 106%, after a $794 million after-tax impairment charge on skin health goodwill and intangibles.
Base Business EPS rose 4% to $0.95; full-year 2025 GAAP EPS fell 25% to $2.63.
2026 guidance: net sales up 2% to 6%, organic sales growth of 1% to 4%, and GAAP double-digit EPS growth.
Church & Dwight reported fourth-quarter 2025 net sales of $1,644.2 million, up 3.9%, and adjusted EPS of $0.86, up 11.7%, while reported EPS fell to $0.60 after a $45.6 million after-tax charge tied to its VMS exit. For 2026, the company expects organic sales growth of 3% to 4% and adjusted EPS growth of 5% to 8%, while reported sales are expected to decline 0.5% to 1.5% because of 2025 business exits.
Q4 2025 organic sales rose 0.7%, below the company's outlook of approximately 1.5%.
Full-year 2025 net sales were $6,203.2 million, up 1.6%, and reported diluted EPS was $3.02 versus $2.37 in 2024.
The quarterly dividend rises 4.2% to $0.3075 per share, payable March 2, 2026.
The company expects Q1 2026 adjusted EPS of $0.92 per share and repurchased $900 million of shares in 2025.
Regeneron reported fourth quarter 2025 total revenues of $3.9 billion, up 3% from a year earlier, while fourth quarter GAAP earnings per diluted share fell 2% to $7.86. For full year 2025, revenues rose 1% to $14.3 billion and GAAP EPS rose 8% to $41.48, and the company also gave full year 2026 financial guidance.
Q4 2025 total revenues were $3,884 million, up 3% from $3,789 million in Q4 2024.
Q4 2025 GAAP EPS was $7.86 versus $8.06; non-GAAP EPS was $11.44 versus $12.07.
Full year 2025 GAAP EPS was $41.48 versus $38.34; full year non-GAAP EPS was $44.31 versus $45.62.
The company repurchased $3.5 billion of its stock in 2025 and declared a $0.94 per share dividend payable March 5, 2026.
Verizon reported fourth-quarter 2025 revenue of $36.4 billion, up 2.0% from a year earlier, and 616,000 postpaid phone net additions, up from 504,000. Reported EPS fell to $0.55 from $1.18 as selling, general and administrative expense rose 26.0%, while adjusted EPS, which excludes special items, was $1.09. The company also guided to 2026 adjusted EPS of $4.90 to $4.95 and free cash flow of $21.5 billion or more, and said the Frontier acquisition closed on January 20, 2026.
Q4 2025 total operating revenue $36.4 billion, up 2.0%; net income $2.4 billion versus $5.1 billion a year earlier
Q4 2025 EPS $0.55 (diluted $0.55 vs $1.18) and adjusted EPS $1.09; full-year 2025 EPS $4.06 and adjusted EPS $4.71
2026 outlook: adjusted EPS $4.90 to $4.95, 750,000 to 1.0 million postpaid phone net additions, free cash flow of $21.5 billion or more
Frontier acquisition closed January 20, 2026, expanding fiber access to over 30 million homes and businesses
Autoliv reported fourth-quarter 2025 net sales of $2,817 million, up 7.7%, and adjusted diluted EPS of $3.19, up 4.7%, while GAAP diluted EPS fell 3.8% to $2.98. For full year 2026 it guided to around 0% organic sales growth, an adjusted operating margin of around 10.5-11.0%, and operating cash flow of around $1.2 billion, and said Q1 2026 adjusted operating margin will be considerably weaker than Q1 2025.
Q4 2025 net sales of $2,817 million, up 7.7%; organic sales growth of 4.2%
Diluted EPS of $2.98 (down 3.8%); adjusted diluted EPS of $3.19 (up 4.7%)
Full year 2026 guidance: organic sales growth around 0%, adjusted operating margin around 10.5-11.0%
Management expects Q1 2026 adjusted operating margin to be considerably weaker than Q1 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.